Navigation Links
Researchers develop magnetic molecular machines to deliver drugs to unhealthy cells
Date:8/10/2010

Scientists from UCLA's California NanoSystems Institute and Korea's Yonsei University have developed an innovative method that enables nanomachines to release drugs inside living cancer cells when activated remotely by an oscillating magnetic field.

The new system the first to utilize a class of porous nanomaterials driven by a magnetic core has the potential to improve both targeted drug-delivery and magnetic resonance imaging in the treatment of cancer and other diseases.

The research appears in the July issue of the Journal of the American Chemical Society.

In recent years, cancer research has increasingly focused on developing therapies that, unlike chemotherapy, target only cancer cells while leaving healthy cells unharmed. To that end, scientists have created nanomachines that can trap and release drug molecules from pores directly into individual cancer cells in response to a stimulus.

While many methods have been created for controlling how and when pores load and unload their cargos, for therapeutic applications, an external and noninvasive method of activation is preferable for the most effective results.

The new method, developed by the research groups of Jeffrey Zink, a UCLA professor of chemistry and biochemistry, and Jinwoo Cheon, a professor of chemistry at Korea's Yonsei University, uses a material that combines a framework of mesoporous silica nanoparticles with magnetic zinc-doped iron oxide nanocrystals, along with attached nanovalves that help hold drug molecules in the pores. When a magnetic-field stimulus is applied, the valves open and release the drug molecules from the pores into the target cells.

"The hydrophobic nature of the interior of the pores, as well as the ability to functionalize the silica surface with hydrophilic functionalities, makes these particles attractive for anti-cancer drug delivery," Zink said. "Adding a magnetic core to the silica-based nanoparticles is of interest for its potential applications in magnetic resonance imaging, as addition of the magnetic core may make it useful as a contrast agent."

For this study, nanoparticles carrying the anti-cancer drug doxorubicin were introduced to and endocytosed by breast cancer cells. When the cancer cells containing the nanoparticles were then exposed to an oscillating magnetic field, cell death occurred.

"The novel magnetic-core silica nanoparticles are effective in activating nanovalves which release anti-cancer drugs when they are exposed to an oscillating magnetic field," Zink said.

The magnetic-field oscillation causes the zinc-doped iron oxide nanocrystals to heat. This increased heat causes the molecular machines to activate, and the doxorubicin in the pores is delivered into the cells.

"Magnetic nanocrystals are important in biomedical applications because they can be used for both therapeutics and imaging," said Cheon, director of the National Creative Research Initiative Center for Evolutionary Nanoparticles and the H.G. Underwood Professor of Chemistry and division head of the Nano-Medical National Core Research Center at Yonsei University.

"The ability to deliver anti-cancer drugs only to the cancer cells without affecting healthy cells is of key importance," added Cheon who is also a visiting professor at UCLA's CNSI.

Experiments for the research project were performed by UCLA graduate students Courtney Thomas and Daniel Ferris and Yonsei University graduate students Je-Hyun Lee and Eunsook Kim, who are part of the research group of professor Jeon-Soo Shin. The research team also involved Fraser Stoddard, a professor of chemistry at Northwestern University who began his collaboration with Zink while he was a professor of chemistry at UCLA. During his UCLA tenure, Stoddart served as Fred Kavli Chair of Nanosystems Sciences and director of the CNSI, positions now held by distinguished professor of chemistry Paul S. Weiss.

The next step in the research will be to examine the effects in vivo and to determine if we can use this to offer precise control over location of delivered drugs. The ultimate goal would be to develop this system to have applicability in treatment of cancer patients.


'/>"/>

Contact: Jennifer Marcus
jmarcus@cnsi.ucla.edu
310-267-4839
University of California - Los Angeles
Source:Eurekalert

Related medicine news :

1. UCLA researchers discover protein that shuttles RNA into cell mitochondria
2. Help wanted: Highly cited researchers needed for high-ranking positions at research institutions
3. NIST researchers measure high infrared power levels from some green lasers
4. Mayo Clinic researchers share latest findings in CT radiation dose reduction efforts
5. Researchers develop advanced search tool to help physicians sort and retrieve vital EMR data
6. Researchers identify key enzyme in DNA repair pathway
7. Researchers study benefits of white button mushrooms
8. Use of decision-aid program increases safety for women experiencing abuse, researchers find
9. Researchers uncover biological rationale for why intensive lupus treatment works
10. OHSU Knight Cancer Institute researchers isolate importance of gene in breast cancer prognosis
11. Researchers pinpoint key stem cells for eating and sex
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/10/2016)... ... 10, 2016 , ... United Benefit Advisors (UBA), the nation’s ... to its growing list of Partner Firms. S.S. Nesbitt is headquartered in ... Huntsville and in between. , Harnessing the experience and insights of the agency’s ...
(Date:2/10/2016)... ... 2016 , ... AHRA: The Association for Medical Imaging Management ... will serve as keynote speaker at the organization’s 2016 Spring Conference. Fox’s topic, ... effectively communicate with their own organizational staff and leadership. , “I am ...
(Date:2/10/2016)... Palm Beach, Florida (PRWEB) , ... February 10, ... ... & Country Club) announced that it has been awarded the prestigious Distinguished Emerald ... the World award program conducted by BoardRoom magazine, one of the most respected ...
(Date:2/10/2016)... ... February 10, 2016 , ... Workrite Ergonomics this week ... series of monitor mounts ever. , “Our goal was to develop a product ... install system that we have ever created.” said Darren Hulsey, Product Manager for Workrite ...
(Date:2/10/2016)... ... , ... A new leadership team for Mid-South Youth Camp, operated by Freed-Hardeman ... announcement Monday night, Feb. 8, prior to the evening session of the university’s 80th ... of GO! Camp, has been named director. Gayle McDonald, currently the assistant director of ...
Breaking Medicine News(10 mins):
(Date:2/10/2016)... 10, 2016 Urologix, the market leader for ... Benign Prostatic Hyperplasia (BPH), announces new private ownership and ... a medical device industry veteran of more than 20 ... Company.  Plymouth, Minn. ... ThermoTherapy™ and Prostiva® RF Therapy, will continue to be ...
(Date:2/10/2016)... -- A Worldwide Clinical Trials expert will present ... Park Plaza in London , 24-25 February ... future advances for late phase research on Wednesday, 24 Feb ... associate director of project management at Worldwide, will focus on ... and standards in late phase research. --> ...
(Date:2/10/2016)... DIEGO , Feb. 10, 2016  Visage ... Pro Medicus Ltd. (ASX: PME), has announced that the ... of Florida (UF) have selected the Visage 7 ... viewer of the Emergent/Critical Care Imaging SIMulation (SIM). ... in Diagnostic Imaging Program (WIDI), a multi-faceted and ...
Breaking Medicine Technology: